Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Mona Bafadhel(National Institute for Health and Care Research), Dan V. Nicolau(Queensland University of Technology), Robin Fox(Bicester Community Hospital), Peter J. Barnes(Imperial College London), Richard Russell(Southern Health NHS Foundation Trust), Philippa C. Matthews(University College London Hospitals NHS Foundation Trust), Helen Jeffers(University of Oxford), Christine Mwasuku(National Institute for Health and Care Research), Mahdi Mahdi(National Institute for Health and Care Research), Nabil T. Fadai(University of Nottingham), Ian Binnian, Stephen Bright(Edith Cowan University), Jennifer Cane(National Institute for Health and Care Research), Andreas Halner(University of Oxford), Jodie L. Simpson(Hunter Medical Research Institute), Christopher Butler(University of Oxford), Stefan Peterson(Public Health Agency of Sweden), Karolina Krassowska(National Institute for Health and Care Research), Thomas Bengtsson(WeMind), Beverly Langford(National Institute for Health and Care Research), Victoria Glover(Horse Hospital), Jonathan Baker(King's College London), Louise Donnelly(Lung Institute)
Cited by 25
Related Papers
The cytokine network in asthma and chronic obstructive pulmonary disease
|Journal of Clinical Investigation|2008|968
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
|British Journal of Pharmacology|2006|812
Chronic obstructive pulmonary disease
|Nature Reviews Disease Primers|2015|733